Physician-Patient Responsible for Ban on Power Morcellators, Dies
Amy J. Reed, MD, died 4 years following her surgery that used a power morcellator to remove her uterus, resulting in the spread of a hidden cancer.
She developed stage 4 leiomyosarcoma following a routine hysterectomy that was meant to take care of her fibroids. Amy J. Reed, MD,
The reason: use of a power morcellator that slices the tissue into small pieces that can then be extracted through minimally invasive surgery, which allows for faster recovery. However, what went unnoticed was that if a patient has cancer, the power morcellator accelerates the spread of cancer—this happened with Reed.
Reed’s surgery was conducted at Brigham and Women’s Hospital in Boston, within the Harvard Medical School, where she and her husband, Hooman Noorchashm, MD, hold teaching positions. A biopsy post surgery was the first diagnosis of Reed’s cancer—the morcellator had sprayed her malignant cells around her abdomen. Despite aggressive chemotherapy, radiation therapy, and immunotherapy, she suffered multiple recurrences in her abdomen, lungs, and spine.
The couple then took their case to regulatory authorities, as well as device makers, hospitals, and multiple other organizations, to raise awareness around the danger of the power morcellator. They also enlisted other women who had undergone the procedure, or their families, to join the campaign. The primary result of their effort was a study conducted and publicized by the FDA that found hidden sarcomas were
Subsequently, the FDA
Aetna was the first health plan to take a stand in reaction to the FDA decision. In the summer of 2015, the company
Reed leaves behind her husband and 6 children.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025